Results 231 to 240 of about 14,938,680 (293)

Distinct profiles of circulating lymphocytes reflect clinical and serological variations in idiopathic inflammatory myopathies. [PDF]

Reumatologia
Opinc-Rosiak A, Sarnik J, Makowska J.
europepmc   +1 more source

The Role of miRNAs in Chicken Immune Regulation and Prospects for Disease‐Resistant Breeding

Animal Research and One Health, EarlyView.
A schematic workflow illustrating the screening of disease‐resistant miRNAs and the generation of miRNA‐based disease‐resistant chickens via PGC‐mediated germline genome editing. ABSTRACT MicroRNAs (miRNAs) are emerging as pivotal regulators of the immune system, playing a decisive role in shaping disease resistance in chicken.
Qiangzhou Wang, Weiran Wu, Qingqing Cai, Jiaxing Wang, Qi Gao, Muhammad Iftikhar, Yulin Bi, Hao Bai, Lihong Gu, Guobin Chang, Shihao Chen   +10 more
wiley   +1 more source

A pilot study investigating the comparison of immunological responses to two immunosuppressive regimens in a porcine model. [PDF]

Front Vet Sci
Pulido M, Báez-Díaz C, Álvarez V, Vázquez-López F, Vives J, Raya A, Casado JG, Sánchez-Margallo FM, Crisóstomo V, López E.   +9 more
europepmc   +1 more source

A Mouse Model of Depression‐Tumor Multimorbidity Reveals the Mechanism of Tumor Growth Accelerated by Depression

Animal Research and One Health, EarlyView.
Depression accelerates tumor growth by dysregulation of tumor immune microenvironment. (A) Modeling methods: Subcutaneous tumor models were established under chronic unpredictable mild stress conditions, including cold swimming, physical restraint, and food/water deprivation, leading to increased tumor growth.
Yakun Ren, Xinpei Wang, Wen Wang, Xingjiu Yang, Mengyuan Li, Jing Du, Ran Gao   +6 more
wiley   +1 more source

From suspected lymphoma to self-limiting lymphadenitis: Kikuchi-Fujimoto disease in focus. [PDF]

J Hematop
Rieck J, Dittmayer C, Janz M, Horst D, Schallenberg S.   +4 more
europepmc   +1 more source

Interleukin‐2 Deprived State of Regulatory T cells and Their Recovery by Low‐Dose Interleukin‐2 in Patients With Inflammatory Myopathies

Arthritis &Rheumatology, EarlyView.
Objective Regeneration and expansion of Treg by low‐dose interleukin‐2 (IL‐2) therapy is considered a potential treatment strategy for a wide range of autoimmune diseases. To provide a pathophysiologically‐based rationale for low‐dose IL‐2 therapy, we investigated whether reversible defects in the Treg–IL‐2 axis emerge in inflammatory myopathies ...
Justus Ohmes, Luisa R. Monne, Sara Comdühr, Fynn Gerlach, Hanna Grasshoff, Alexander Dübbers, Antje Müller, Alexander Scheffold, Gabriela Riemekasten, Reza Akbarzadeh, Jens Y. Humrich   +10 more
wiley   +1 more source

From Oncolysis to Adaptive Immunity: Yellow Fever Virus 17D and Ruxolitinib Activate Antitumor Immune Responses in Pancreatic Cancer Models. [PDF]

Biomedicines
Trachuk KN, Biryukova YK, Kapranov VA, Nazarenko AS, Orlova EA, Kozhemyakin GL, Demyashkin GA, Gordeychuk IV, Ishmukhametov AA, Kolyasnikova NM.   +9 more
europepmc   +1 more source

Non-classical immune checkpoint CD137/CD137L and CD200/CD200R expressions are regulated by the tumor immune microenvironment in lymph node aspirates from lung cancer patients. [PDF]

Front Immunol
Kwiecień I, Raniszewska-Borys A, Rutkowska E, Sokołowski R, Jahnz-Różyk K, Rzepecki P.   +5 more
europepmc   +1 more source

Comparative study of the tumor-infiltrating lymphocytes before and after neoadjuvant chemoimmunotherapy in esophageal squamous cell carcinoma. [PDF]

J Cardiothorac Surg
Xu Y, Wang H, Wang N, Cui S, Guo J, Huang C, Wang M, Su P, Qi J, Tian Z.   +9 more
europepmc   +1 more source

Cytokine and Lymphocyte Profiles in COVID-19 Patients with Cancer: Implications for Disease Severity and Clinical Outcomes. [PDF]

Viruses
Burlá MM, Silva KL, Peixoto BC, Goes LR, Azevedo-Quintanilha I, Bozza FA, Soares MA, de Melo AC, Hottz ED, Bozza PT, Viola JPB.   +10 more
europepmc   +1 more source